FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 60 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | – | 389 | +87.9% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 207 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 207 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 207 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 207 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | – | 207 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 1,000,000 | $7,330,000 | 3.56% |
| Sio Capital Management, LLC | 336,286 | $2,465,000 | 1.69% |
| Opaleye Management Inc. | 285,000 | $2,089,000 | 1.03% |
| SENZAR ASSET MANAGEMENT, LLC | 864,408 | $6,336,111,000 | 0.92% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,350,847 | $9,902,000 | 0.74% |
| Ghost Tree Capital, LLC | 150,000 | $1,100,000 | 0.50% |
| PURA VIDA INVESTMENTS, LLC | 102,000 | $748,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 380,000 | $2,785,000 | 0.36% |
| J. Goldman & Co LP | 474,810 | $3,480,000 | 0.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 948,934 | $6,956,000 | 0.27% |